<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="diseases caused by dengue, Japanese encephalitis, West Nile, Zika, and" exact="chikungunya" post="viruses. Major gaps in protection against the most significant"/>
 <result pre="flaviviruses and alphaviruses. These include the dengue virus (DENV), Japanese" exact="encephalitis" post="virus (JEV), West Nile virus (WNV), and Zika virus"/>
 <result pre="virus (WNV), and Zika virus (ZIKV) which are flaviviruses, and" exact="chikungunya" post="virus (CHIKV) which is an alphavirus (refer to Table"/>
 <result pre="have been observed. For instance, hemorrhagic fever in DENV infections," exact="encephalitis" post="in JEV and WNV infections; severe myalgia and arthralgia"/>
 <result pre="the case of ZIKV infections, an increased occurrence of congenital" exact="microcephaly" post="and Guillainâ€&quot;BarrÃ© syndrome was reported in ZIKV outbreak areas"/>
 <result pre="include DENV, JEV, WNV, ZIKV, and many others such as" exact="yellow fever" post="virus and hepatitis C virus (HCV). 2.1. Dengue Virus"/>
 <result pre="ZIKV, and many others such as yellow fever virus and" exact="hepatitis" post="C virus (HCV). 2.1. Dengue Virus (DENV) Transmitted by"/>
 <result pre="Encephalitis Virus (JEV) JEV is the leading cause of viral" exact="encephalitis" post="in Asia with approximately 68,000 cases of infection estimated"/>
 <result pre="pigs and/or wading water birds; humans are incidental hosts. Japanese" exact="encephalitis" post="is primarily a disease of children, with ~75% of"/>
 <result pre="in Brazil [50,51]. Symptoms of ZIKV infection resembles that of" exact="dengue fever," post="which includes fever, headache, rashes, and joint and muscle"/>
 <result pre="been associated with ZIKV infections. An increased occurrence of congenital" exact="microcephaly" post="resulting from abnormal brain development, as well as Guillainâ€&quot;BarrÃ©"/>
 <result pre="brain development, as well as Guillainâ€&quot;BarrÃ© syndrome (GBS) and acute" exact="myelitis" post="in adults were reported in ZIKV outbreak areas [14,52,53,54,55]."/>
 <result pre="were reported in ZIKV outbreak areas [14,52,53,54,55]. Long-term consequences of" exact="microcephaly" post="can range from mild developmental delays to severe motor"/>
 <result pre="pain, myalgia, and polyarthralgia [57,63]. Complications of CHIKV infection include" exact="respiratory failure" post="and meningoencephalitis [13]. Some patients have been reported to"/>
 <result pre="polyarthralgia [57,63]. Complications of CHIKV infection include respiratory failure and" exact="meningoencephalitis" post="[13]. Some patients have been reported to experience recurrent"/>
 <result pre="However, its symptoms may be clinically indistinguishable from dengue and" exact="chikungunya" post="fever, hence leading to the misdiagnosis and underestimation of"/>
 <result pre="exhibit broad-spectrum antiviral activity against several enveloped viruses including PR8" exact="influenza" post="virus, vaccinia virus, pseudorabies virus, Newcastle disease virus [98],"/>
 <result pre="antiviral activity against several enveloped viruses including PR8 influenza virus," exact="vaccinia virus," post="pseudorabies virus, Newcastle disease virus [98], HCV [120], and"/>
 <result pre="and has shown to possess potent antiviral activity against HIV," exact="influenza" post="virus, herpes simplex virus (HSV), and HCV [92,101,122,123]. A"/>
 <result pre="shown to possess potent antiviral activity against HIV, influenza virus," exact="herpes simplex" post="virus (HSV), and HCV [92,101,122,123]. A direct virucidal effect"/>
 <result pre="an important anti-malarial agent which has been used to treat" exact="malaria" post="from as early as the 1600s [130]. It was"/>
 <result pre="It was shown to exert antiviral activity on HSV [131]," exact="influenza" post="[132], and DENV [109]. A study sought to repurpose"/>
 <result pre="produces mild to severe side effects at therapeutic concentrations in" exact="malaria" post="treatment [130]. Mild symptoms include headache, nausea, and tinnitus;"/>
 <result pre="is used as a supportive treatment for chronic liver diseases," exact="hepatocellular carcinoma," post="and liver cirrhosis [134]. In a two-year toxicity study"/>
 <result pre="supportive treatment for chronic liver diseases, hepatocellular carcinoma, and liver" exact="cirrhosis" post="[134]. In a two-year toxicity study of silymarin conducted"/>
 <result pre="Screen.20161955456410.2174/138620731966616050612340127151484 22.RodriguezA.K.MunozA.L.SeguraN.A.RangelH.R.BelloF.Molecular characteristics and replication mechanism of dengue, zika and" exact="chikungunya" post="arboviruses, and their treatments with natural extracts from plants:"/>
 <result pre="encephalitisJ. Neurol. Neurosurg. Psychiatry20006840541510.1136/jnnp.68.4.40510727474 34.Van GesselY.KladeC.S.PutnakR.FormicaA.KrasaesubS.SpruthM.CenaB.TungtaengA.GettayacaminM.DewasthalyS.Correlation of protection against Japanese" exact="encephalitis" post="virus and JE vaccine (IXIAROÂ®) induced neutralizing antibody titersVaccine2011295925593110.1016/j.vaccine.2011.06.06221723353"/>
 <result pre="Zika Virus Infection and Microcephalyâ€&quot;Brazil, 2015Morb. Mortal. Wkly Rep.201665596210.15585/mmwr.mm6503e226820244 54.MÃ©charlesS.M.D.HerrmannC.M.D.PoullainP.M.D.TranT.-H.M.B.DeschampsN.M.B.MathonG.M.D.LandaisA.M.D.BreurecS.M.D.LannuzelA.P.Acute" exact="myelitis" post="due to Zika virus infectionLancet2016387148110.1016/S0140-6736(16)00644-926946926 55.CarteauxG.MaquartM.BedetA.ContouD.BrugiÃ¨resP.FouratiS.de LangavantL.C.de BrouckerT.Brun-BuissonC.Leparc-GoffartI.et al.Zika"/>
 <result pre="evidence from Sri Lanka and SingaporeJ. Gen. Virol.2010911067107610.1099/vir.0.015743-019955565 68.HochedezP.HausfaterP.JaureguiberryS.GayF.DatryA.DanisM.BricaireF.BossiP.Cases of" exact="chikungunya" post="fever imported from the islands of the South West"/>
 <result pre="enveloped viruses infectivity by curcuminPLoS ONE20138e6248210.1371/journal.pone.006248223658730 99.MounceB.C.CesaroT.CarrauL.ValletT.VignuzziM.Curcumin inhibits Zika and" exact="chikungunya" post="virus infection by inhibiting cell bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 100.WeberC.SlivaK.Von RheinC.KÃ¼mmererB.M.SchnierleB.S.The"/>
 <result pre="bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 100.WeberC.SlivaK.Von RheinC.KÃ¼mmererB.M.SchnierleB.S.The green tea catechin, epigallocatechin gallate inhibits" exact="chikungunya" post="virus infectionAntivir. Res.20151131310.1016/j.antiviral.2014.11.00125446334 101.CarneiroB.M.BatistaM.N.BragaA.C.S.NogueiraM.L.RahalP.The green tea molecule EGCG inhibits"/>
 <result pre="J. Mol. Sci.201920186010.3390/ijms20081860 114.LaniR.HassandarvishP.ChiamC.W.MoghaddamE.ChuJ.J.H.RausaluK.MeritsA.HiggsS.VanlandinghamD.Abu BakarS.et al.Antiviral activity of silymarin against" exact="chikungunya" post="virusSci. Rep.201551142110.1038/srep1142126078201 115.CaminiF.C.da SilvaT.F.da Silva CaetanoC.C.AlmeidaL.T.FerrazA.C.Alves VitoretiV.M.de Mello SilvaB.de"/>
 <result pre="ComplianceClin. Cancer Res.2004106847685410.1158/1078-0432.CCR-04-074415501961 120.ColpittsC.C.SchangL.M.RachmawatiH.FrentzenA.PfaenderS.BehrendtP.BrownR.J.P.BankwitzD.SteinmannJ.OttM.et al.Turmeric curcumin inhibits entry of all" exact="hepatitis" post="C virus genotypes into human liver cellsGut2014631137114910.1136/gutjnl-2012-30429923903236 121.MazumderA.RaghavanK.WeinsteinJ.KohnK.W.PommierY.Inhibition of"/>
 <result pre="integrase by curcuminBiochem. Pharmacol.1995491165117010.1016/0006-2952(95)98514-A7748198 122.CallandN.AlbeckaA.BelouzardS.WychowskiC.DuverlieG.DescampsV.HoberD.DubuissonJ.RouillÃ©Y.SÃ©ronK.(âˆ’)-Epigallocatechin-3-gallate is a new inhibitor of" exact="hepatitis" post="C virus entryHepatology20125572072910.1002/hep.2480322105803 123.YamaguchiK.HondaM.IkigaiH.HaraY.ShimamuraT.Inhibitory effects of (âˆ’)-epigallocatechin gallate on"/>
 <result pre="SilymarinComplement. Med. Res.20081592010.1159/00011364818334810 137.WagonerJ.NegashA.KaneO.J.MartinezL.E.NahmiasY.BourneN.OwenD.M.GroveJ.BrimacombeC.McKeatingJ.A.et al.Multiple effects of silymarin on the" exact="hepatitis" post="C virus lifecycleHepatology2010511912192110.1002/hep.2358720512985 138.Wilder-SmithA.VanniceK.DurbinA.HombachJ.ThomasS.J.IraniT.SimmonsC.P.Zika vaccines and therapeutics: Landscape analysis"/>
</results>
